Investment Thesis
With R&D expenses rising, the global pharma industry is increasingly relying on data analytics for speedier and cost-effective clinical trials. The new approach has the backing of the FDA, which recently approved new therapies based on the real-world data. The global tech giants are shaking up the industry competition with their technical and financial prowess. The large bio-pharma players have already taken note of the trend, snapping up clinical data providers at lofty multiples.
However, IQVIA Holdings Inc. (IQV), a firm offering contract research services backed by data insights, has slumped